Innovation requires collaboration
Our mission is to have a significant impact on healthcare. We aim to be a front runner in the development of sustainable, innovative, and affordable healthcare.
What we do
Aiosyn raises EUR 2 million to develop AI-powered algorithms to support pathologists with clinical diagnostics21 December 2022
Nijmegen, the Netherlands – Aiosyn is developing a diagnostics platform that uses artificial intelligence to support pathologists with more accurate and efficient clinical diagnostics.
Joining forces increases innovation Janssen and Radboud1 December 2022
Dr. Eng Kinga Matuła (KM), specialist in single-cell multi-omics and Jeroen Van Houdt (JH), Omics group leader at Janssen Pharmaceutica, answer three pressing questions about the successful collaboration in the single-cell technology project.